Stockscreener 앱 받기
40.65
0.49%
0.20
시간 외 거래:
41.00
0.35
+0.86%
Qiagen Nv 주식(QGEN)의 최신 뉴스
QGEN: New Data Highlights Efficacy of QuantiFERON-TB Gold Plus T - GuruFocus
Qiagen announces newly published data supporting efficacy of QuantiFERON - TipRanks
In people with HIV, a TB blood test cut disease risk 41% and cost less - Stock Titan
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Headwinds Amid Genomics Slowdown and Strategic Shifts - AD HOC NEWS
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
Release according to Article 40, Section 1 of the WpHG - TradingView
Moors & Cabot Inc. Acquires 154,851 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. Stock (ISIN: NL0012169213) Drops 16.85% in March Amid Diagnostics Sector Headwinds - AD HOC NEWS
BlackRock Reports 10.6% Capital and 11.8% Voting Stake in Qiagen - The Globe and Mail
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Pressure Amid Life Sciences Slowdown - AD HOC NEWS
Wellington Management Group LLP Lowers Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Position Raised by Perbak Capital Partners LLP - MarketBeat
Dnca Finance Acquires 39,063 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen NV (QGEN) - MSN
BlackRock Discloses 10.29% Capital Interest and 11.43% Voting Stake in Qiagen - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen (NYSE:QGEN) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft - MarketBeat
Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus
Deutsche Bank Upgrades Qiagen NV(QGEN.US) to Buy Rating - 富途牛牛
Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat
Deutsche Bank upgrades Qiagen stock rating to buy on valuation By Investing.com - Investing.com India
Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com
QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com
Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider
Qiagen Q2 2025 Earnings Preview - MSN
Capital International Investors Boosts Holdings in Qiagen N.V. $QGEN - MarketBeat
Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance
Qiagen discloses Bank of America’s 3.05% stake following AFM notification - TipRanks
Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat
Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Capital Group Private Client Services Inc. Reduces Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen gains after guidance raise - MSN
BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights - TipRanks
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System - BioSpace
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - pharmiweb.com
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat
Qiagen at Leerink Global Healthcare Conference: Strategic Growth and Challenges - Investing.com India
CEO Change: Is Qiagen NV exposed to political risk2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? - Yahoo Finance
Victory Capital Management Inc. Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Did Qiagen’s Strategic Review Signal A Sale, Or Just A SHIFT Toward Capital Returns? - Smartkarma
Segall Bryant & Hamill LLC Lowers Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - The Globe and Mail
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
QIAGEN Updates Total Voting Rights to 206.8 Million - TipRanks
BlackRock Discloses 11.56% Voting Stake in QIAGEN - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
Qiagen Discloses Supervisory Board Member’s Restricted Stock Unit Settlement - The Globe and Mail
Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks
Qiagen Reports Grant of Restricted Stock Units to Board Member - TipRanks
Qiagen Grants Performance Stock Units to Managing Board Member - TipRanks
QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks
Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks
QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
0.55%
2.50%
자본화:
|
볼륨(24시간):